NOTCH1 and prostate carcinoma: Furthermore, the high expression levels of Notch1 and its ligand, Jagged-1, have been associated with a poor prognosis in breast cancer, bladder cancer, leukemia, intrahepatic cholangiocarcinoma and prostate cancer (17–22).